BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,858,137 | -17.2% | 605,674 | 0.0% | 0.03% | -21.4% |
Q2 2023 | $27,594,507 | +12.3% | 605,674 | 0.0% | 0.04% | +7.7% |
Q1 2023 | $24,566,137 | +0.1% | 605,674 | +25.8% | 0.04% | -9.3% |
Q4 2022 | $24,540,322 | +2.6% | 481,466 | +8.4% | 0.04% | +4.9% |
Q3 2022 | $23,921,000 | +46.6% | 444,133 | +74.8% | 0.04% | +51.9% |
Q2 2022 | $16,317,000 | -42.2% | 254,033 | -30.2% | 0.03% | -28.9% |
Q1 2022 | $28,227,000 | -54.0% | 364,033 | -49.1% | 0.04% | -41.5% |
Q4 2021 | $61,405,000 | +0.6% | 715,341 | -5.7% | 0.06% | -5.8% |
Q3 2021 | $61,017,000 | -6.6% | 758,629 | -6.5% | 0.07% | -11.5% |
Q2 2021 | $65,337,000 | +23.3% | 811,634 | +29.2% | 0.08% | +13.0% |
Q1 2021 | $52,994,000 | -38.6% | 628,334 | -41.6% | 0.07% | -46.5% |
Q4 2020 | $86,299,000 | +113.8% | 1,075,513 | +114.3% | 0.13% | +69.7% |
Q3 2020 | $40,362,000 | -0.4% | 501,890 | +6.6% | 0.08% | -12.6% |
Q2 2020 | $40,531,000 | -43.0% | 470,748 | -46.3% | 0.09% | -53.5% |
Q1 2020 | $71,159,000 | +43.7% | 876,445 | +48.0% | 0.19% | +92.8% |
Q4 2019 | $49,518,000 | -6.2% | 592,174 | -1.9% | 0.10% | -11.0% |
Q3 2019 | $52,785,000 | +21.3% | 603,463 | +13.6% | 0.11% | +23.9% |
Q2 2019 | $43,510,000 | +12.0% | 531,254 | +11.2% | 0.09% | +17.3% |
Q1 2019 | $38,838,000 | +31.9% | 477,654 | +6.8% | 0.08% | +13.6% |
Q4 2018 | $29,439,000 | -68.6% | 447,301 | -63.2% | 0.07% | -61.8% |
Q3 2018 | $93,754,000 | +3.4% | 1,216,157 | -1.0% | 0.17% | -0.6% |
Q2 2018 | $90,702,000 | -35.4% | 1,228,354 | -43.1% | 0.17% | -26.3% |
Q1 2018 | $140,311,000 | -4.2% | 2,157,304 | -4.8% | 0.24% | -14.2% |
Q4 2017 | $146,491,000 | +65.2% | 2,266,254 | +60.4% | 0.28% | +51.9% |
Q3 2017 | $88,669,000 | +40.8% | 1,413,054 | +35.8% | 0.18% | +25.7% |
Q2 2017 | $62,995,000 | +35.5% | 1,040,554 | +16.1% | 0.14% | +19.0% |
Q1 2017 | $46,475,000 | +24.1% | 896,154 | +6.1% | 0.12% | -11.0% |
Q4 2016 | $37,448,000 | +2.1% | 844,563 | +9.6% | 0.14% | +1.5% |
Q3 2016 | $36,669,000 | +67.5% | 770,363 | +59.1% | 0.13% | +50.6% |
Q2 2016 | $21,889,000 | +116.9% | 484,063 | +97.1% | 0.09% | +111.9% |
Q1 2016 | $10,090,000 | +634.4% | 245,625 | +487.4% | 0.04% | +600.0% |
Q3 2015 | $1,374,000 | -26.5% | 41,818 | +56.4% | 0.01% | 0.0% |
Q2 2015 | $1,869,000 | +2.9% | 26,730 | +0.8% | 0.01% | -14.3% |
Q1 2015 | $1,816,000 | -44.1% | 26,514 | -40.2% | 0.01% | -30.0% |
Q4 2014 | $3,248,000 | +53.9% | 44,322 | +50.7% | 0.01% | +42.9% |
Q3 2014 | $2,111,000 | +12.6% | 29,410 | +13.4% | 0.01% | +16.7% |
Q2 2014 | $1,875,000 | -72.9% | 25,932 | -72.4% | 0.01% | -77.8% |
Q1 2014 | $6,915,000 | +8.9% | 93,976 | +2.9% | 0.03% | +3.8% |
Q4 2013 | $6,350,000 | -36.0% | 91,308 | -39.6% | 0.03% | -40.9% |
Q3 2013 | $9,925,000 | +27.3% | 151,081 | +34.2% | 0.04% | +12.8% |
Q2 2013 | $7,799,000 | – | 112,582 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |